The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...

Nov. 25, 2022 — An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID combination vaccine for approval in 2024Announces positive ...

Vaxxas today announced that it has initiated a multi-center Phase I clinical trial of a vaccine against pre-pandemic avian ...

Derived from the Latin adjuvare (to help or aid), adjuvants enhance antigen-specific vaccine immunogenicity. Added only when ...

Some information you come across about COVID-19 may be out of date or false. Learn about COVID-19 myths so you can bust them when you see them.

The DOH said the submission of bids on the procurement of the flu vaccines was scheduled on Friday. But this was the fifth time the procurement had been rescheduled since the department published ...

EL PASO, Texas (KFOX14/CBS4) — A local vaccine advocacy group is now immunizing people with three types of flu vaccines depending on their age and allergies. Immunize El Paso, a Borderland ...

Flu season is approaching in the United States. Here's what you can expect this year — and when to get your flu vaccine to ...

inactivated virus vaccines to produce a stronger immune response in the body. It’s approved for individuals 65 and older, per the CDC. Cell-based flu shot: This flu shot contains virus that was ...